L

Lantheus Holdings

D
LNTH
USD
-2.97
(-3.2527%)
Market Closed
104,448.00
حجم التداول
6.55
الربح لكل سهم
-
العائد الربحي
14.530
P/E
6,133,502,914.28
حجم السوق
اليوم
-3.2527%
1 اسبوع
-19.574%
1 شهر
-17.067%
6 اشهر
16.283%
12 اشهر
35.803%
بداية السنة
42.323%
كل الوقت
968.198%

Title:
Lantheus Holdings

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
هل تحتاج مساعدة او لديك استفسار؟